These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 2295804

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C, Weiss J.
    J Immunol; 1996 Jun 15; 156(12):4789-96. PubMed ID: 8648126
    [Abstract] [Full Text] [Related]

  • 23. Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.
    Jin H, Yang R, Marsters S, Ashkenazi A, Bunting S, Marra MN, Scott RW, Baker JB.
    J Clin Invest; 1995 Apr 15; 95(4):1947-52. PubMed ID: 7706502
    [Abstract] [Full Text] [Related]

  • 24. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
    Schultz H, Weiss J, Carroll SF, Gross WL.
    J Leukoc Biol; 2001 Apr 15; 69(4):505-12. PubMed ID: 11310835
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter.
    Lennartsson A, Vidovic K, Pass MB, Cowland JB, Gullberg U.
    J Leukoc Biol; 2006 Jul 15; 80(1):196-203. PubMed ID: 16684888
    [Abstract] [Full Text] [Related]

  • 27. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM.
    Pediatrics; 1999 Dec 15; 104(6):1327-33. PubMed ID: 10585984
    [Abstract] [Full Text] [Related]

  • 28. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR, Lamping N, Hoess A.
    J Immunol; 1997 Dec 01; 159(11):5599-605. PubMed ID: 9548502
    [Abstract] [Full Text] [Related]

  • 29. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R, Marra MN, McKelligon BM, Lonnemann G, Schulzeck P, Schulze M, Oppermann M, Shaldon S.
    Clin Nephrol; 1993 Dec 01; 40(6):346-51. PubMed ID: 7507806
    [Abstract] [Full Text] [Related]

  • 30. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D, Schnare M, Saake M, Röllinghoff M, Gessner A.
    Infect Immun; 2006 Aug 01; 74(8):4708-14. PubMed ID: 16861658
    [Abstract] [Full Text] [Related]

  • 31. Presence of bactericidal/permeability-increasing protein in human and rat skin.
    Takahashi M, Horiuchi Y, Tezuka T.
    Exp Dermatol; 2004 Jan 01; 13(1):55-60. PubMed ID: 15009116
    [Abstract] [Full Text] [Related]

  • 32. A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow.
    Lennartsson A, Pieters K, Vidovic K, Gullberg U.
    J Leukoc Biol; 2005 Mar 01; 77(3):369-77. PubMed ID: 15590754
    [Abstract] [Full Text] [Related]

  • 33. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
    Elsbach P.
    Ciba Found Symp; 1994 Mar 01; 186():176-87; discussion 187-9. PubMed ID: 7768151
    [Abstract] [Full Text] [Related]

  • 34. [The study on the role of modeling peptides derived from bactericidal/permeability increasing protein on the endotoxin neutralization].
    Zheng J, Zhou H, Lu Y, Xiao G.
    Zhonghua Shao Shang Za Zhi; 2002 Apr 01; 18(2):95-8. PubMed ID: 12515655
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O, Sisson RB, Kenyon J, Eichenwald E, Macone AB, Goldmann D.
    Infect Immun; 2000 Sep 01; 68(9):5120-5. PubMed ID: 10948134
    [Abstract] [Full Text] [Related]

  • 36. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C, Chen S, Sidorczyk Z, Elsbach P, Weiss J.
    Infect Immun; 1994 Jan 01; 62(1):259-65. PubMed ID: 8262637
    [Abstract] [Full Text] [Related]

  • 37. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ, Dahlberg PS, Ratz CA, Johnston JW, Gray BH, Haseman JR, Mayo KH, Dunn DL.
    Surgery; 1995 Aug 01; 118(2):318-24. PubMed ID: 7638748
    [Abstract] [Full Text] [Related]

  • 38. Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface.
    Nishimura H, Gogami A, Miyagawa Y, Nanbo A, Murakami Y, Baba T, Nagasawa S.
    Immunology; 2001 Aug 01; 103(4):519-25. PubMed ID: 11529944
    [Abstract] [Full Text] [Related]

  • 39. Extracellular release of bactericidal/permeability-increasing protein in newborn infants.
    Nupponen I, Turunen R, Nevalainen T, Peuravuori H, Pohjavuori M, Repo H, Andersson S.
    Pediatr Res; 2002 Jun 01; 51(6):670-4. PubMed ID: 12032259
    [Abstract] [Full Text] [Related]

  • 40. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin.
    Elsbach P, Weiss J.
    Curr Opin Immunol; 1993 Feb 01; 5(1):103-7. PubMed ID: 8452666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.